FindTrial
Sign In

Conventional GnRH Antagonist Protocol Versus Segmentation Protocol

Conventional GnRH Antagonist Protocol Versus Segmentation Protocol In Patients Undergoing Intracytoplasmic Sperm Injection (ICSI)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201802003072343
Enrollment
60
Registered
2018-02-11
Start date
2016-11-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fertility-female Infertility

Interventions

Segmentation protocol
Standard antagonist protocol

Sponsors

Department of Obstetrics and Gynaecology, Faculty of Medicine, University of Alexandria
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: The period of infertility is at least 1 year. All patients will be indicated for IVF or ICSI.

Exclusion criteria

Exclusion criteria: - endometriosis. - Azoospermia. - Previous history of ovarian or pelvic surgery. - Congenital uterine abnormalities even if corrected. - Poor responders.

Design outcomes

Primary

MeasureTime frame
Clinical Pregnancy Rate (CPR).—

Secondary

MeasureTime frame
Quality of embryos transferred. ;Occurrence of Ovarian Hyperstimulation syndrome (OHSS).—

Countries

Egypt

Contacts

Public ContactElsayedamr Basma

Patient Information Manager

elsayedamr@yahoo.com00201223106023

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026